University of Free State prepares for clinical trial of Ivermectin

Farmovs, a wholly owned clinical research company of the University of the Free State (UFS) – together with several medical and scientific experts at the university – are preparing a clinical trial protocol to determine the efficacy of Ivermectin for Covid-19 in a randomised, controlled study in order to submit it for approval to the relevant regulatory authority.

The statement from UFS yesterday came as AfriForum announced it had brought an urgent court application against the South African Health Products Regulatory Authority (Sahpra) and Health Minister Dr Zweli Mkhize “to ensure that ivermectin developed for human consumption is available to doctors who want to prescribe it to treat Covid-19”.

While the drug has been approved for humans in combating worms, Sahpra has maintained that its use in tackling coronavirus has not been proved, nor has it been approved for use in tackling the virus.

“Farmovs is a South African specialty full-service clinical research organisation conducting ICH-GCP-compliant Phase I to IVclinical trials,” the UFS statement
read.

Notice: Coronavirus reporting at Caxton Local Media aims to combat fake news

Dear reader,
As your local news provider, we have the duty of keeping you factually informed on Covid-19 developments. As you may have noticed, mis- and disinformation (also known as “fake news”) is circulating online. Caxton Local Media is determined to filter through the masses of information doing the rounds and to separate truth from untruth in order to keep you adequately informed. Local newsrooms follow a strict pre-publication fact-checking protocol. A national task team has been established to assist in bringing you credible news reports on Covid-19.
Readers with any comments or queries may contact National Group Editor Irma Green (irma@caxton.co.za) or Legal Adviser Helene Eloff (helene@caxton.co.za).